|
1
|
Cleophas MCP, Crişan TO, Klück V,
Hoogerbrugge N, Netea-Maier RT, Dinarello CA, Netea MG and Joosten
LAB: Romidepsin suppresses monosodium urate crystal-induced
cytokine production through upregulation of suppressor of cytokine
signaling 1 expression. Arthritis Res Ther. 21:502019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roddy E and Choi HK: Epidemiology of gout.
Rheum Dis Clin North Am. 40:155–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mbuyi N and Hood C: An update on gout
diagnosis and management for the primary care provider. Nurse
Pract. 45:16–25. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ragab G, Elshahaly M and Bardin T. Gout:
An old disease in new perspective-a review. J Adv Res. 8:495–511.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dewulf JP, Marie S and Nassogne MC:
Disorders of purine biosynthesis metabolism. Mol Genet Metab.
136:190–198. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu YR, Wang JQ and Li J: Role of NLRP3 in
the pathogenesis and treatment of gout arthritis. Front Immunol.
14:11378222023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Sun W, Gao F, Lu J, Li K, Xu Y,
Li Y, Li C and Chen Y: Changes of serum uric acid level during
acute gout flare and related factors. Front Endocrinol (Lausanne).
14:10770592023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Richette P, Doherty M, Pascual E, Barskova
V, Becce F, Castaneda J, Coyfish M, Guillo S, Jansen T, Janssens H,
et al: 2018 updated European league against rheumatism
evidence-based recommendations for the diagnosis of gout. Ann Rheum
Dis. 79:31–38. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu AM and Brown JN: Comparative effect of
allopurinol and febuxostat on long-term renal outcomes in patients
with hyperuricemia and chronic kidney disease: A systematic review.
Clin Rheumatol. 39:3287–3294. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rasheed Kayani R, Shamim R, Sultana Munir
S, Sultana M, Nazir SUR, Riaz H, Nazir T, Maaz Ali M and Islam A:
Medicinal plants and nonsteroidal anti-inflammatory drugs (NSAIDs)
in treatment of arthritis: A literature review. Altern Ther Health
Med. 28:58–64. 2022.PubMed/NCBI
|
|
11
|
Hainer BL, Matheson E and Wilkes RT:
Diagnosis, treatment, and prevention of gout. Am Fam Physician.
90:831–836. 2014.PubMed/NCBI
|
|
12
|
Lucas G and Droney L: Severe adverse drug
reaction to allopurinol. Aust Prescr. 45:130–131. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Febuxostat, . Updated advice suggests
caution in patients with a history of cardiovascular disease. React
Wkly 1960. 52023.
|
|
14
|
Ali S, Drendel AL, Rosychuk RJ, May SL,
McGrath P, Carleton B and Johnson WD: LO049: Ibuprofen or
oxycodone? An observational cohort study of post-emergency
department discharge management of children's fracture pain. CJEM.
18 (Suppl 1):S472016. View Article : Google Scholar
|
|
15
|
Keller SF and Mandell BF: Management and
cure of gouty arthritis. Rheum Dis Clin North Am. 48:479–492. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Atrahimovich D, Avni D and Khatib S:
Flavonoids-macromolecules interactions in human diseases with focus
on Alzheimer, atherosclerosis and cancer. Antioxidants (Basel).
10:4232021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li G, Ding K, Qiao Y and Zhang L, Zheng L,
Pan T and Zhang L: Flavonoids regulate inflammation and oxidative
stress in cancer. Molecules. 25:56282020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chagas MDSS, Behrens MD, Moragas-Tellis
CJ, Penedo GXM, Silva AR and Gonçalves-de-Albuquerque CF: Flavonols
and flavones as potential anti-inflammatory, antioxidant, and
antibacterial compounds. Oxid Med Cell Longev. 2022:99667502022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Sun C, Zhou S, Zhao W, Wang L,
Sheng L, Yi J, Liu T, Yan J, Ma X and Fang B: Recent advances in
chemistry and bioactivity of Sargentodoxa cuneata. J
Ethnopharmacol. 270:1138402021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dhanasekar C and Rasool M: Morin, a
dietary bioflavonol suppresses monosodium urate crystal-induced
inflammation in an animal model of acute gouty arthritis with
reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl
transferase, and inflammatory mediators. Eur J Pharmacol.
786:116–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang C, Zhao M, Jiang B, Yu J, Hao Q, Liu
W, Hu Z, Zhang Y and Song C: Extraction optimization, structural
characterization and potential alleviation of hyperuricemia by
flavone glycosides from celery seeds. Food Funct. 13:9832–9846.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng S, Wu S, Xie F, Yang CS and Shao P:
Natural compounds lower uric acid levels and hyperuricemia:
Molecular mechanisms and prospective. Trends Food Sci Tech.
123:87–102. 2022. View Article : Google Scholar
|
|
23
|
Altunayar-Unsalan C and Unsalan O:
Molecular structure, antioxidant potential, and pharmacokinetic
properties of plant flavonoid blumeatin and investigating its
inhibition mechanism on xanthine oxidase for hyperuricemia by
molecular modeling. ACS Omega. 9:13284–13297. 2024.PubMed/NCBI
|
|
24
|
Li J, Li S, Song Q, Ma E and Aimaijiang M:
Mechanism of total flavonoids from Ampelopsis grossedentata against
gouty arthritis based on multi-level interactive network and in
vivo experimental validation. Zhongguo Zhong Yao Za Zhi.
47:4733–4743. 2022.(In Chinese). PubMed/NCBI
|
|
25
|
Huang J, Song Y, Zhao P, Feng Y and Liu Y:
Experimental Study of Rutin in the Treatment of Acute Gouty
Arthritis. Mil Med Joint Logist. 27:533–535+539. 2013.
|
|
26
|
Wu H, Wang Y, Huang J, Li Y, Lin Z and
Zhang B: Rutin ameliorates gout via reducing XOD activity,
inhibiting ROS production and NLRP3 inflammasome activation in
quail. Biomed Pharmacother. 158:1141752023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang J, Zhu M, Tao Y, Wang S, Chen J, Sun
W and Li S: Therapeutic properties of quercetin on monosodium urate
crystal-induced inflammation in rat. J Pharm Pharmacol.
64:1119–1127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qian X and Jiang Y, Luo Y and Jiang Y: The
anti-hyperuricemia and anti-inflammatory effects of atractylodes
macrocephala in hyperuricemia and gouty arthritis rat models. Comb
Chem High Throughput Screen. 26:950–964. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sato VH, Chewchinda S, Parichatikanond W
and Vongsak B: In vitro and in vivo evidence of hypouricemic and
anti-inflammatory activities of Maclura cochinchinensis
(Lour.) Corner heartwood extract. J Tradit Complement Med.
10:85–94. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nematbakhsh M, Hajhashemi V, Ghannadi A,
Talebi A and Nikahd M: Protective effects of the Morus alba
L. leaf extracts on cisplatin-induced nephrotoxicity in rat. Res
Pharm Sci. 8:71–77. 2013.PubMed/NCBI
|
|
31
|
Lin Y, Liu PG, Liang WQ, Hu YJ, Xu P, Zhou
J, Pu JB and Zhang HJ: Luteolin-4′-O-glucoside and its aglycone,
two major flavones of Gnaphalium affine D. Don, resist
hyperuricemia and acute gouty arthritis activity in animal models.
Phytomedicine. 41:54–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang AH, Jin Y, Wu Y, Cheng XF, Tian QH,
Xie Q and Liu W: Research progress on treatment of gout by xanthine
oxidase inhibitor in traditional Chinese medicine. Tianjin J Tradit
Chin Med. 36:1241–1245. 2019.
|
|
33
|
Mudgal R and Singh S: Xanthine
oxidoreductase in the pathogenesis of endothelial dysfunction: An
update. Curr Hypertens Rev. Feb 2–2024.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bardin T and Richette P: Novel
uricosurics. Rheumatology (Oxford). 57 (Suppl 1):i42–i46. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu QH, Zhu JX, Ning LI and Miao MX: Effect
of jasminoidin on potassium oxonate-induced hyperuricemia in mice
and its mechanism. Cent S Pharm. 11:721–725. 2013.
|
|
36
|
Cheng Y and Li F: Current status of
research on uric acid transporter proteins. J Hubei Univ Med.
36:470–473+486. 2017.
|
|
37
|
George RL and Keenan RT: Genetics of
hyperuricemia and gout: Implications for the present and future.
Curr Rheumatol Rep. 15:3092013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Anzai N, Ichida K, Jutabha P, Kimura T,
Babu E, Jin CJ, Srivastava S, Kitamura K, Hisatome I, Endou H and
Sakurai H: Plasma urate level is directly regulated by a
voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
J Biol Chem. 283:26834–26838. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
So A and Thorens B: Uric acid transport
and disease. J Clin Invest. 120:1791–1799. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Johnson RJ, Sanchez-Lozada LG and Nakagawa
T: The effect of fructose on renal biology and disease. J Am Soc
Nephrol. 21:2036–2039. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wikoff WR, Nagle MA, Kouznetsova VL,
Tsigelny IF and Nigam SK: Untargeted metabolomics identifies
enterobiome metabolites and putative uremic toxins as substrates of
organic anion transporter 1 (Oat1). J Proteome Res. 10:2842–2851.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bush KT, Wu W, Lun C and Nigam SK: The
drug transporter OAT3 (SLC22A8) and endogenous metabolite
communication via the gut-liver-kidney axis. J Biol Chem.
292:15789–15803. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nigam SK and Bhatnagar V: The systems
biology of uric acid transporters: The role of remote sensing and
signaling. Curr Opin Nephrol Hypertens. 27:305–313. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Woodward OM, Köttgen A, Coresh J,
Boerwinkle E, Guggino WB and Köttgen M: Identification of a urate
transporter, ABCG2, with a common functional polymorphism causing
gout. Proc Natl Acad Sci USA. 106:10338–10342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Luo S, Cui X and Li X: Uric acid
transporter in the kidney. Prog Physiol Sci. 50:231–235. 2019.
|
|
46
|
Zhang HJ, Li LN, Zhou J, Yang QQ, Liu PG,
Xu P, Liang WQ, Cheng L, Zhang YQ, Pu JB, et al: Effects of
Gnaphalium affine D. Don on hyperuricemia and acute gouty
arthritis. J Ethnopharmacol. 203:304–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Caporali S, De Stefano A, Calabrese C,
Giovannelli A, Pieri M, Savini I, Tesauro M, Bernardini S, Minieri
M and Terrinoni A: Anti-inflammatory and active biological
properties of the plant-derived bioactive compounds luteolin and
luteolin 7-glucoside. Nutrients. 14:11552022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jiang Y, Lin Y, Hu YJ, Song XJ, Pan HH and
Zhang HJ: Caffeoylquinic acid derivatives rich extract from
Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia
and acute gouty arthritis in animal model. BMC Complement Altern
Med. 17:3202017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li P, Ren G, Sun Y, Jiang D and Liu C:
Extraction optimization, preliminary identification, and
bioactivities in corn silk. Evid Based Complement Alternat Med.
2023:56851742023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xv G: Determination on the contents of the
flavonoids and the nutritive components in different parts of three
corns. J Henan Univ Technol (Natural Science Edition). 82–84.
2001.
|
|
51
|
Li P, Song J, Li Q, Zhang Q, Cui H, Guan
B, Zhao Y and Song Z: Curative effect analysis of flavone extract
from Stigma Maydis on rats of modified acute gouty arthritis model.
China Mod Med. 25:8–11. 2018.
|
|
52
|
Chi X, Ye H, Ma C, Yue H, Guo J, Lin Z,
Sun J, Ye D, Huang X and Lu G: Effect of total flavonoids in corn
stigma on uric acid uptake and related gene expression in HK-2
cells. Pharmacol Clini Chin Mater Med. 36:95–100. 2020.(In
Chinese).
|
|
53
|
Niu Y, Li Q, Tu C, Li N, Gao L, Lin H,
Wang Z, Zhou Z and Li L: Hypouricemic actions of the pericarp of
mangosteen in vitro and in vivo. J Nat Prod. 86:24–33. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hu QH, Zhang X, Wang Y and Kong LD:
Mangiferin promotes uric acid excretion and kidney function
improvement and modulates related renal transporters in
hyperuricemic mice. Yao Xue Xue Bao. 45:1239–1246. 2010.(In
Chinese). PubMed/NCBI
|
|
55
|
Cobo I, Cheng A, Murillo-Saich J, Coras R,
Torres A, Abe Y, Lana AJ, Schlachetzki J, Liu-Bryan R, Terkeltaub
R, et al: Monosodium urate crystals regulate a unique JNK-dependent
macrophage metabolic and inflammatory response. Cell Rep.
38:1104892022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lee YM, Cho SN, Son E, Song CH and Kim DS:
Apamin from bee venom suppresses inflammation in a murine model of
gouty arthritis. J Ethnopharmacol. 257:1128602020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cui R, Li M, Tuerxun G, Li Y and Xie S:
Research on the role of toll-like receptor 2 and toll-like receptor
4 and its signal pathway in the pathogenesis of primary gout
arthritis. Matrix Sci Pharma. 4:12020. View Article : Google Scholar
|
|
58
|
Jeong JH, Hong S, Kwon OC, Ghang B, Hwang
I, Kim YG, Lee CK and Yoo B: CD14+ cells with the
phenotype of infiltrated monocytes consist of distinct populations
characterized by anti-inflammatory as well as pro-inflammatory
activity in gouty arthritis. Front Immunol. 8:12602017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Akahoshi T: Pathological mechanisms of
gouty arthritis. Nihon Rinsho. 66:705–710. 2008.(In Japanese).
PubMed/NCBI
|
|
60
|
Cronstein BN and Sunkureddi P: Mechanistic
aspects of inflammation and clinical management of inflammation in
acute gouty arthritis. J Clin Rheumatol. 19:19–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Luo H, Tan J, Wei G, Huang L and JL:
Advances in the pathogenesis, diagnosis and treatment of gout.
Intern Med. 14:47–50. 2019.
|
|
62
|
Dai X, Fang X, Xia Y, Li M and Li X, Wang
Y, Tao J and Li X: ATP-activated P2X7R promote the attack of acute
gouty arthritis in rats through activating NLRP3 inflammasome and
inflammatory cytokine production. J Inflamm. 15:1237–1248. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Xue Y, Li R, Fang P, Ye ZQ, Zhao Y, Zhou
Y, Zhang KQ and Li L: NLRP3 inflammasome inhibitor cucurbitacin B
suppresses gout arthritis in mice. J Mol Endocrinol. 67:27–40.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Han J, Shi G, Li W, Xie Y, Li F and Jiang
D: Preventive effect of dioscin against monosodium urate-mediated
gouty arthritis through inhibiting inflammasome NLRP3 and
TLR4/NF-κB signaling pathway activation: An in vivo and in vitro
study. J Nat Med. 75:37–47. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ou X, Ding T, Yang H, et al: Research
progress of signal pathway related to pathogenesis of gouty
arthritis. Pharmacol Clin Chin Mater Med. 37:234–240. 2021.
|
|
66
|
Kelley N, Jeltema D, Duan Y and He Y: The
NLRP3 inflammasome: An overview of mechanisms of activation and
regulation. Int J Mol Sci. 20:33282019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hulse J and Bhaskar K: Crosstalk between
the NLRP3 inflammasome/ASC speck and amyloid protein aggregates
drives disease progression in Alzheimer's and Parkinson's disease.
Front Mol Neurosci. 15:8051692022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang M, Zhu Y, Zhao H and Zhao HF:
Moxibustion intervention improves synovitis by down-regulating
NLRP3/Caspase-1/IL-1β signaling of synovial tissue in rats with
adjuvant arthritis. Zhen Ci Yan Jiu. 48:1111–1116. 2023.(In
English, Chinese). PubMed/NCBI
|
|
69
|
Li X and Yang N: Exosome miR-223-3p in the
bone marrow-derived mesenchymal stem cells alleviates the
inflammation and airway remodeling through NLRP3-induced
ASC/Caspase-1/GSDMD signaling pathway. Int Immunopharmacol.
123:1107462023. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li Z, Guo J and Bi L: Role of the NLRP3
inflammasome in autoimmune diseases. Biomed Pharmacother.
130:1105422020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang X, Liu Y, Deng G, Huang B, Kai G,
Chen K and Li J: A purified biflavonoid extract from selaginella
moellendorffii alleviates gout arthritis via NLRP3/ASC/Caspase-1
axis suppression. Front Pharmacol. 12:6762972021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Rong S, Wan D, Fan Y, Liu S, Sun K, Huo J,
Zhang P, Li X, Xie X, Wang F and Sun T: Amentoflavone affects
epileptogenesis and exerts neuroprotective effects by inhibiting
NLRP3 inflammasome. Front Pharmacol. 10:8562019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Çevik D, Erdogan S, Serttas R, Kan Y and
Kırmızıbekmez H: Cytotoxic and antimigratory activity of
retrochalcones from Glycyrrhiza echinata L. on human cancer
cells. Chem Biodivers. 20:e2022005892023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Staurengo-Ferrari L, Ruiz-Miyazawa KW,
Pinho-Ribeiro FA, Fattori V, Zaninelli TH, Badaro-Garcia S, Borghi
SM, Carvalho TT, Alves-Filho JC, Cunha TM, et al: Trans-chalcone
attenuates pain and inflammation in experimental acute gout
arthritis in mice. Front Pharmacol. 9:11232018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sun X, Li P, Qu X and Liu W: Isovitexin
alleviates acute gouty arthritis in rats by inhibiting inflammation
via the TLR4/MyD88/NF-κB pathway. Pharm Biol. 59:1326–1333. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L,
Peng C and Li Y: Phillygenin inhibits LPS-induced activation and
inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. J
Ethnopharmacol. 248:1123612020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Takeda K and Akira S: Toll-like receptors.
Curr Protoc Immunol. 109:14.12.1–14.12.10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zaninelli TH, Fattori V, Saraiva-Santos T,
Badaro-Garcia S, Staurengo-Ferrari L, Andrade KC, Artero NA, Ferraz
CR, Bertozzi MM, Rasquel-Oliveira F, et al: RvD1 disrupts
nociceptor neuron and macrophage activation and neuroimmune
communication, reducing pain and inflammation in gouty arthritis in
mice. Br J Pharmacol. 179:4500–4515. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Tian J, Zhou D, Xiang L, Xie B, Wang B, Li
Y and Liu X: Calycosin represses AIM2 inflammasome-mediated
inflammation and pyroptosis to attenuate monosodium urate-induced
gouty arthritis through NF-κB and p62-Keap1 pathways. Drug Dev Res.
83:1654–1672. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang F, Cao J, Li Y, Ren F, Bai J, Dong Q
and Guo J: Study of quality markers of antiuric acid formula by
grey relational analysis. SN Appl Sci. 3:6612021. View Article : Google Scholar
|
|
81
|
Xiong W, Zhang H, Wen L, Wang X, Zhong G,
Shi Y, Du X and Zhu J: Effect of Lagotis brachystachys Maxim
extract on xanthine oxidase and renal urate transporters in
hyperuricemia mice. Chin J New Drugs. 27:1538–1543. 2018.
|
|
82
|
Shan J, Ouyang X, Yang H, Wei R, Liu Y,
Zhong G, Liu H and Zhu J: Study on the effective parts of
Lagotis brachystachys Maxim against acute gouty arthritis in
rats. Tradit Chin Drug Res Clin Pharmacol. 32:492–498. 2021.(In
Chinese).
|
|
83
|
Shi Y, Li X, Wen L, Zeng J, Zhong G, Yao
X, Mu Z, Wang X and Zhu J: Anti-acute alcoholic liver injure
effects and mechanism of Lagotis brachystachy and lagotis
brevituba. Tradit Chin Drug Res Clin Pharmacol. 28:600–605.
2017.(In Chinese).
|
|
84
|
Wang L, Zhang H, Shi Y, Li M, Mu Z, Zhong
G, Zhu J and Wang H: Chemical constituents from Lagotis
brachystachy. Chin Tradit Patent Med. 42:2926–2930. 2020.(In
Chinese).
|
|
85
|
Nishitani Y, Yamamoto K, Yoshida M, Azuma
T, Kanazawa K, Hashimoto T and Mizuno M: Intestinal
anti-inflammatory activity of luteolin: role of the aglycone in
NF-κB inactivation in macrophages co-cultured with intestinal
epithelial cells. Biofactors. 39:522–533. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Luan RL, Meng XX and Jiang W: Protective
effects of apigenin against paraquat-induced acute lung injury in
mice. Inflammation. 39:752–758. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li Q, Tian Z, Wang M, Kou J, Wang C, Rong
X, Li J, Xie X and Pang X: Luteoloside attenuates neuroinflammation
in focal cerebral ischemia in rats via regulation of the
PPARγ/Nrf2/NF-κB signaling pathway. Int Immunopharmacol.
66:309–316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ouyang X, Li NZ, Guo MX, Zhang MM, Cheng
J, Yi LT and Zhu JX: Active flavonoids from Lagotis
brachystachya attenuate monosodium urate-induced gouty
arthritis via inhibiting TLR4/MyD88/NF-κB pathway and NLRP3
expression. Front Pharmacol. 12:7603312021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Shen R, Ma L and Zheng Y:
Anti-inflammatory effects of luteolin on acute gouty arthritis rats
via TLR/MyD88/NF-κB pathway. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
45:115–122. 2020.(In English, Chinese). PubMed/NCBI
|
|
90
|
Lee MN, Lee Y, Wu D and Pae M: Luteolin
inhibits NLRP3 inflammasome activation via blocking ASC
oligomerization. J Nutr Biochem. 92:1086142021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Wang Z, Chen W, Li Y, Zhang S, Lou H, Lu X
and Fan X: Reduning injection and its effective constituent
luteoloside protect against sepsis partly via inhibition of
HMGB1/TLR4/NF-κB/MAPKs signaling pathways. J Ethnopharmacol.
270:1137832021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhao F, Dang Y, Zhang R, Jing G, Liang W,
Xie L and Li Z: Apigenin attenuates acrylonitrile-induced
neuro-inflammation in rats: Involved of inactivation of the
TLR4/NF-κB signaling pathway. Int Immunopharmacol. 75:1056972019.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zhu JX, Yang HY, Hu WQ, Cheng J, Liu Y, Yi
LT and Cheng HY: Active components from Lagotis
brachystachya maintain uric acid homeostasis by inhibiting
renal TLR4-NLRP3 signaling in hyperuricemic mice.
Inflammopharmacology. 29:1187–1200. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Newsholme P, Cruzat VF, Keane KN, Carlessi
R and de Bittencourt PIH Jr: Molecular mechanisms of ROS production
and oxidative stress in diabetes. Biochem J. 473:4527–4550. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wójcik P, Gęgotek A, Žarković N and
Skrzydlewska E: Oxidative stress and lipid mediators modulate
immune cell functions in autoimmune diseases. Int J Mol Sci.
22:7232021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Cheng JJ, Ma XD, Ai GX, Yu QX, Chen XY,
Yan F, Li YC, Xie JH, Su ZR and Xie QF: Palmatine protects against
MSU-induced gouty arthritis via regulating the NF-κB/NLRP3 and Nrf2
pathways. Drug Des Devel Ther. 16:2119–2132. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zeng D, Yin C, Wei H, Li Y, Yang Y, Nie H,
Pan Y, Xu R, Tai Y, Du J, et al: Activation of Nrf2 antioxidant
signaling alleviates gout arthritis pain and inflammation. Biomed
Pharmacother. 170:1159572024. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zamudio-Cuevas Y, Hernández-Díaz C, Pineda
C, Reginato AM, Cerna-Cortés JF, Ventura-Ríos L and López-Reyes A:
Molecular basis of oxidative stress in gouty arthropathy. Clin
Rheumatol. 34:1667–1672. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wu H, Wang Y, Ren Z, Li Y, Huang J, Lin Z
and Zhang B: Overnutrition-induced gout: An immune response to
NLRP3 inflammasome dysregulation by XOD activity increased in
quail. Front Immunol. 13:10748672022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Maiuolo J, Oppedisano F, Gratteri S,
Muscoli C and Mollace V: Regulation of uric acid metabolism and
excretion. Int J Cardiol. 213:8–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kiltz U, Alten R, Fleck M, Krüger K,
Manger B, Müller-Ladner U, Nüsslein H, Reuss-Borst M, Schwarting A,
Schulze-Koops H, et al: Evidence-based recommendations for
diagnostics and treatment of gouty arthritis in the specialist
sector : S2e guidelines of the German society of rheumatology in
cooperation with the AWMF. Z Rheumatol. 76:118–124. 2017.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhao S: Clinical efficacy of traditional
Chinese medicine soup in the treatment of gout with damp-heat
stasis and the pharmacological effects of total flavonoids of the
monarch extract Poria cocos (Poria cocos). Capital Food Med.
26:187–188. 2019.
|
|
103
|
Engel B, Just J, Bleckwenn M and
Weckbecker K: Treatment options for gout. Dtsch Arztebl Int.
114:215–222. 2017.PubMed/NCBI
|
|
104
|
Levy RM, Pillai L and Burnett PB:
Nutritional benefits of flavocoxid in patients with osteoarthritis:
Efficacy and safety. Nutr Diet Suppl. 2:27–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
